By Kelly Knaub ( October 28, 2013, 2:07 PM EDT) -- A putative class of Catalyst Pharmaceutical Partners Inc. investors on Thursday accused the company in Florida federal court of inflating its stock price by misrepresenting its orphan drug Firdapse as new, when another company had been giving it away for decades....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.